ArticleMolecular therapy. Oncology2026

Engineering potent TILs from an immune-excluded tumor: Insights from chondrosarcoma.

Rusul Al-Marayaty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.